BACKGROUND
1. Field of the Invention
This invention relates to analogs of glycyl-L-prolyl-L-glutamic acid (GPE). In particular, this invention relates to neuroprotective GPE analogs, to methods of making them, to pharmaceutical compositions containing them, and to their use in treating neurological
BACKGROUND OF THE INVENTION
(1) Field of the Invention
The present invention generally relates to compounds having pharmacological activity which are useful as pharmacological agents and, more particularly, as analgesic agents for the treatment of pain, to pharmaceutical compositions containing one
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a method of indicating the probability of non-epileptic seizures, such as psychogenic non-epileptic seizures (PNES), wherein the method comprises the steps: automatically recording data on a patient by means of a
BACKGROUND OF THE INVENTION
(a) Field of Invention
The invention relates to a method for ameliorating or preventing generalized tonic-clonic type seizures associated with epilepsy which involves systemically administering to a mammal in need of such treatment a benzothiazepine calcium channel
TECHNICAL FIELD
The present disclosure relates to systems, methods and media for detecting seizures.
BACKGROUND
Someone experiencing a seizure may be unable to call for help. During the seizure, the person having a seizure may lose voluntary muscle control and be unable to call for assistance.
BACKGROUND OF THE INVENTION
The present invention relates to the field of medical devices to treat neurological disorders of the brain.
Complex dynamic systems that are open to energy/mass and/or information exchanges with their environment typically display emergent properties of self organization
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a system for detecting seizures, such as tonic-clonic seizures, comprising: at least one processor unit capable of recording an electromyographic signal from a sensor unit, one or more analysis modules configured to
TECHNICAL FIELD
The present disclosure relates to systems, methods and media for detecting seizures.
BACKGROUND
Someone experiencing a seizure may be unable to call for help. During the seizure, the person having a seizure may lose voluntary muscle control and be unable to call for assistance.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to and the benefit of U.S. Nonprovisional application Ser. No. 15/396,263, filed Dec. 30, 2016, and titled "Seizure Detection", which is incorporated by reference in its entirety.
TECHNICAL FIELD
The present disclosure relates
TECHNICAL FIELD
The present invention relates to electroconvulsive therapy (ECT) and more particularly an improved electroconvulsive therapy (ECT) treatment including methodology for simultaneously and accurately predicting seizure adequacy during treatment.
RELATED ART
Electroconvulsive therapy
TECHNICAL FIELD
Methods of treating developmental disorders and/or seizure disorders with etifoxine are provided.
BACKGROUND
Treatments for developmental disorders such as Autistic Spectrum Disorder, Dravet syndrome, Rett syndrome, Angelman syndrome, Fragile X syndrome, and Fragile X-associated
FIELD OF THE INVENTION
The present invention relates to bridged dianilino compounds and pharmaceutical compositions and method of use thereof for the prevention and treatment of epilepsies, seizures, and other electroconvulsive disorders. Specifically, this invention relates to the use of
BACKGROUND
Temporal lobe epilepsy is the most common focal epilepsy in adolescents and adults, and the most frequent indication for epilepsy surgery. Mesial temporal lobe epilepsy (MTLE) often originates from the hippocampus, which is implicated in declarative memory function. A clinical trial in
FIELD OF THE INVENTION
The invention relates to prediction and control methods and systems to treat neurological disorders. In particular, the invention relates to epileptic seizure prediction and treatment methods and systems.
BACKGROUND OF THE INVENTION
Epilepsy is a multifaceted neurological
CROSS REFERENCE TO RELATED APPLICATIONS
The application is related to application Ser. No. 11/975,465 filed on Oct. 19, 2007 for bone microenvironment modulated migraine treatments. Application Ser. No. 11/975,465 disclosed novel etiology underlying certain types of headaches and migraines, whereby
Najkompletnija baza ljekovitog bilja potpomognuta naukom
Radi na 55 jezika
Biljni lijekovi potpomognuti naukom
Prepoznavanje biljaka po slici
Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
Pročitajte naučne publikacije povezane sa vašom pretragom
Pretražite ljekovito bilje po učincima
Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi. * Sve informacije temelje se na objavljenim naučnim istraživanjima